Literature DB >> 31177822

Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.

Shoichi Kuramitsu1, Masanobu Ohya2, Tomohiro Shinozaki3, Hiromasa Otake4, Kazunori Horie5, Hiroyoshi Kawamoto6, Futoshi Yamanaka7, Masahiro Natsuaki8, Hiroki Shiomi9, Gaku Nakazawa10, Kenji Ando1, Kazushige Kadota2, Shigeru Saito7, Takeshi Kimura9.   

Abstract

Background The risk factors and long-term clinical outcomes of patients with definite stent thrombosis (ST) after second-generation drug-eluting stent (DES) implantation have not yet been adequately assessed. Methods and Results The REAL-ST (Retrospective Multicenter Registry of ST After First- and Second-Generation DES Implantation) included 313 definite ST of second-generation DES (early ST, n=179; late ST, n=66; very late ST, n=68). Four patients without definite ST of second-generation DES were identified as control patients for each ST case. Risk factors of definite ST were mostly different according to the timing of ST: ST-segment-elevation myocardial infarction, non-ST-segment-elevation myocardial infarction, and unstable angina at presentation, current smoking, left ventricular ejection fraction <40%, prior percutaneous coronary intervention, stent overlap, severely calcified lesion, left main coronary artery lesion, proximal left anterior descending lesion, postdiameter stenosis ≥20%, for early ST; age <70 years, ST-segment-elevation myocardial infarction at presentation, hemodialysis, left ventricular ejection fraction <40%, in-stent restenosis, and severely calcified lesion for late ST; and proximal left anterior descending lesion and in-stent restenosis for very late ST. Cumulative 4-year incidence of death after the index ST events was significantly higher in the ST patients than control patients (33.0% versus 12.3%, P<0.001 for early ST versus control; 30.6% versus 14.2%, P<0.001 for late ST versus control; and 28.0% versus 13.0%, P<0.001 for very late ST versus control, respectively). Conclusions Risk factors of definite ST after second-generation DES implantation were mostly different according to the timing of ST. Definite ST patients showed unfavorable long-term clinical outcomes compared with those without definite ST. Clinical Trial Registration URL: https://www.umin.ac.jp . Unique identifier: UMIN000025181.

Entities:  

Keywords:  coronary artery disease; drug-eluting stent; percutaneous coronary intervention; stent; thrombosis

Mesh:

Year:  2019        PMID: 31177822     DOI: 10.1161/CIRCINTERVENTIONS.119.007822

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  10 in total

Review 1.  Drug-eluting stent thrombosis: current and future perspectives.

Authors:  Shoichi Kuramitsu; Shinjo Sonoda; Kenji Ando; Hiromasa Otake; Masahiro Natsuaki; Reo Anai; Yasuhiro Honda; Kazushige Kadota; Yoshio Kobayashi; Takeshi Kimura
Journal:  Cardiovasc Interv Ther       Date:  2021-01-13

2.  CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?

Authors:  Dimitri J Maamari; Farouc A Jaffer; Amit V Khera; Akl C Fahed
Journal:  Circulation       Date:  2022-03-07       Impact factor: 29.690

3.  Different types of Kounis syndrome caused by different episodes of bee sting anaphylaxis: Misfortunes never come singly.

Authors:  Kotaro Tsuruta; Kensuke Yokoi; Goro Yoshioka; Wenhann Chen; Kota Jojima; Hiroshi Hongo; Masahiro Natsuaki; Shinjo Sonoda; Nicholas G Kounis; Koichi Node
Journal:  J Cardiol Cases       Date:  2022-03-26

4.  Reducing Endogenous Labile Zn May Help to Reduce Smooth Muscle Cell Injury around Vascular Stents.

Authors:  Zheng Zeng; Yinhong Xie; Li Li; Huanran Wang; Jianying Tan; Xia Li; Qihao Bian; Yu Zhang; Tao Liu; Yajun Weng; Junying Chen
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

5.  Long-Term Outcomes and Clinical Predictors of Mortality Following Occurrence of Stent Thrombosis.

Authors:  Takayuki Ishihara; Katsuki Okada; Hirota Kida; Takuya Tsujimura; Osamu Iida; Shota Okuno; Yosuke Hata; Taku Toyoshima; Naoko Higashino; Atsushi Kikuchi; Tetsuya Watanabe; Takashi Morita; Akihiro Tanaka; Ryu Shutta; Masami Nishino; Shumpei Kosugi; Yasunori Ueda; Yasuhiro Ichibori; Yoshiharu Higuchi; Yohei Sotomi; Daisuke Nakamura; Masahiro Kumada; Shungo Hikoso; Daisaku Nakatani; Toshiaki Mano; Yasushi Sakata
Journal:  J Am Heart Assoc       Date:  2022-04-04       Impact factor: 6.106

6.  Update of the Brazilian Society of Cardiology's Perioperative Cardiovascular Assessment Guideline: Focus on Managing Patients with Percutaneous Coronary Intervention - 2022.

Authors:  Daniela Calderaro; Luciana Dornfeld Bichuette; Pamela Camara Maciel; Francisco Akira Malta Cardozo; Henrique Barbosa Ribeiro; Danielle Menosi Gualandro; Luciano Moreira Baracioli; Alexandre de Matos Soeiro; Carlos Vicente Serrano; Ricardo Alves da Costa; Bruno Caramelli
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

Review 7.  Diabetes and restenosis.

Authors:  Scott Wilson; Pasquale Mone; Urna Kansakar; Stanislovas S Jankauskas; Kwame Donkor; Ayobami Adebayo; Fahimeh Varzideh; Michael Eacobacci; Jessica Gambardella; Angela Lombardi; Gaetano Santulli
Journal:  Cardiovasc Diabetol       Date:  2022-02-14       Impact factor: 9.951

8.  Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study.

Authors:  Luigi Fiocca; Roberta Rossini; Greta Carioli; Alessandra Carobbio; Isabelle Piazza; Elona Collaku; Simona Giubilato; Francesco Amico; Maria Molfese; Mauro De Benedictis; Paolo Calabria; Ugo Limbruno; Serafina Valente; Marco Ferlini; Tiziana Spezzano; Michele Senni; Antonello Gavazzi
Journal:  Int J Cardiol Heart Vasc       Date:  2022-07-18

9.  Intravascular Lithotripsy as a Novel Treatment Method for Calcified Unprotected Left Main Diseases-Comparison to Rotational Atherectomy-Short-Term Outcomes.

Authors:  Piotr Rola; Jan Jakub Kulczycki; Adrian Włodarczak; Mateusz Barycki; Szymon Włodarczak; Marek Szudrowicz; Łukasz Furtan; Artur Jastrzębski; Maciej Pęcherzewski; Maciej Lesiak; Adrian Doroszko
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

10.  Stent thrombosis in acute coronary syndromes: Patient-related factors and operator-related factors.

Authors:  Martin Kamenik; Petr Widimsky
Journal:  Anatol J Cardiol       Date:  2020-10       Impact factor: 1.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.